Cost-Effectiveness of Recently Approved Gene and Cell Therapies for Ultra-Rare Pediatric Disorders: Implications for Genomic Medicine and Expanded Newborn Screening
Cost-Effectiveness of Recently Approved Gene and Cell Therapies for Ultra-Rare Pediatric Disorders: Implications for Genomic Medicine and Expanded Newborn Screening. // Genetics in Medicine Open. – URL: https://www.sciencedirect.com/science/article/pii/S2949774426010332?dgcid=rss_sd_all
Cost-Effectiveness of Recently Approved Gene and Cell Therapies for Ultra-Rare Pediatric Disorders: Implications for Genomic Medicine and Expanded Newborn Screening. Genetics in Medicine Open. https://www.sciencedirect.com/science/article/pii/S2949774426010332?dgcid=rss_sd_all
“Cost-Effectiveness of Recently Approved Gene and Cell Therapies for Ultra-Rare Pediatric Disorders: Implications for Genomic Medicine and Expanded Newborn Screening.” Genetics in Medicine Open.
@article{article3560,
title = {Cost-Effectiveness of Recently Approved Gene and Cell Therapies for Ultra-Rare Pediatric Disorders: Implications for Genomic Medicine and Expanded Newborn Screening},
journal = {Genetics in Medicine Open},
url = {https://www.sciencedirect.com/science/article/pii/S2949774426010332?dgcid=rss_sd_all}
}
ABSTRACT Generating bioengineered cartilage that recapitulates the depth-dependent phenotype, structure, and function of native articular cartilage remains a challenge. While cartilage is rich in aggrecan and type II collagen, proper...